Table 2: Mean insulin dose (U/kg/day ± sem) of 23 subjects treated with continuous subcutaneous insulin infusion (CSII) compared to 23 subjects treated by conventional therapy (CV) at the onset (T1) and at the end (T2) of the study period.

T1 T2 p (ANOVA)
CSII 0.64 ± 0.04 0.70 ± 0.04 0.155
CV 0.57 ± 0.06 0.79 ± 0.03 < 0.001
p (ANOVA) 0.240 0.097